Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
Endocrinology and Metabolism
; : 717-724, 2021.
Article
em En
| WPRIM
| ID: wpr-890497
Biblioteca responsável:
WPRO
ABSTRACT
Active surveillance (AS) for low-risk papillary thyroid microcarcinoma (PTMC) has been accepted worldwide as safe and effective. Despite the growing acceptance of AS in the management of low-risk PTMCs, there are barriers to AS in real clinical settings, and it is important to understand and establish appropriate AS protocol from initial evaluation to follow-up. PTMC management strategies should be decided upon after careful consideration of patient and tumor characteristics by a multidisciplinary team of thyroid cancer specialists. Patients should understand the risks and benefits of AS, participate in decision-making and follow structured monitoring strategies. In this review, we discuss clinical outcomes of AS from previous studies, optimal indications and follow-up strategies for AS, and unresolved questions about AS.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
Endocrinology and Metabolism
Ano de publicação:
2021
Tipo de documento:
Article